Inno Pharma
ActiveSummary
Inno Pharma has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€1,955) and a net result of -€830. Equity has been shrinking by about 104% per year since 2022. Its solvency ranks better than 15% of 75 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Overview
Official details
Source: KBO- Status
- Active since 29-01-2021 Normal situation
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21100
- Establishment unit
- 2.313.727.142 2870 Puurs-Sint-Amands, since 29-01-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 27-03-2026
Board and ownership
- Creafund NVDirector · since 29-01-2021
- Peeters BartDirector · since 29-01-2021
- Van Gucht DominiqueDirector · since 29-01-2021
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.6%
- Gross margin
- -€66
- ▼ 3.0%
- Loss
- €830
- ▼ 2.2%
- Equity
- -€1,955
- ▼ 73.9%
- Total assets
- €1,245
- ▲ 231%
- Negative equity on 31-12-2025
Score breakdownraises riskCapped at 59: negative equityNegative equity -€1,955Loss of €830, the second in a row (financial year 2025)lowers riskSize: total assets €1,245Liquidity: current ratio 0.39, cash €975Show the evidence
Checked score
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, micro). It does better than 10% of them on solvency, 49% on liquidity, 13% on profitability and 12% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 4 accounts on average 18 days before the deadline. In the sector (NACE 21), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
- Risk: Negative equitydebts exceed assets in financial year 2025 -€1,955 View
- Risk: 4 loss-making years in a rowloss in financial year 2025 -€830 View
- Caution: Lower solvency than 85% of companies in pharmaceuticalssector median 35.9% · 75 companies -157.0% View
- Positive: Always filed on timeaccounts within the deadline every year 4 years View
Recent changes
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as Inno Pharma: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21100). They are comparable in size and age: total assets between €5,330 and €10,600, founded between 2008 and 2023.
| Company | Total assets | Gross margin |
|---|---|---|
| Inno Pharma Puurs-Sint-Amands | €1,245 | -€66 |
| Raya Therapeutic Leuven | €5,330 | -€3,717 |
| APCOR R&M Gent | €5,677 | -€11,408 |
| SIRON Lier | €10,632 | -€8,668 |
Key facts about Inno Pharma
- What is the company number of Inno Pharma?
- The company number of Inno Pharma is 0762.694.073. The VAT number is the same number with BE in front: BE 0762.694.073.
- Where is Inno Pharma based?
- The registered office is at Rijksweg 17, 2870 Puurs-Sint-Amands.Company details
- What does Inno Pharma do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21100).
- What is the legal form of Inno Pharma?
- The legal form of Inno Pharma is Private limited company (BV).
- When was Inno Pharma founded?
- Inno Pharma was founded on 29-01-2021.
- Is Inno Pharma still active?
- Yes, Inno Pharma is an active enterprise in the KBO register.
- What is the turnover of Inno Pharma?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is Inno Pharma profitable?
- In financial year 2025, Inno Pharma made a loss of €830.
- Where can I find the annual accounts of Inno Pharma?
- Inno Pharma filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Inno Pharma due?
- Inno Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.